Login / Signup

Obinutuzumab as bridging therapy for successful manufacturing of axicabtagene ciloleucel for transformed follicular lymphoma with circulating cells.

Mohamed A Kharfan-DabajaMichael D JainSonikpreet AulakhErnesto AyalaAbba C ZubairHan W TunHien D LiuFrederick L LockeJulio C Chavez
Published in: American journal of hematology (2019)
Keyphrases
  • induced apoptosis
  • cell cycle arrest
  • endoplasmic reticulum stress
  • cell death
  • oxidative stress